Purpose: Retinoblastoma is the most common primary malignant intraocular tumor in children.Although intraarterial chemontherapy(IAC)has become an essential techniqure in the treatment of advanced intraocular retinoblastoma,the outcomes of IAC as primary therapy for young infants less than 3 months of age with retinoblastoma remains unknown.